Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kodiak Sciences (KOD) EBIT (2017 - 2026)

Kodiak Sciences filings provide 10 years of EBIT readings, the most recent being -$59.8 million for Q1 2026.

  • Quarterly EBIT fell 1.19% to -$59.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$235.1 million through Mar 2026, down 17.62% year-over-year, with the annual reading at -$234.4 million for FY2025, 25.44% down from the prior year.
  • EBIT hit -$59.8 million in Q1 2026 for Kodiak Sciences, down from -$57.5 million in the prior quarter.
  • Across five years, EBIT topped out at -$46.1 million in Q1 2024 and bottomed at -$95.8 million in Q1 2022.
  • Average EBIT over 5 years is -$64.7 million, with a median of -$59.8 million recorded in 2026.
  • The largest annual shift saw EBIT plummeted 89.42% in 2022 before it soared 43.44% in 2024.
  • Kodiak Sciences' EBIT stood at -$74.1 million in 2022, then increased by 14.44% to -$63.4 million in 2023, then increased by 27.13% to -$46.2 million in 2024, then fell by 24.41% to -$57.5 million in 2025, then fell by 4.05% to -$59.8 million in 2026.
  • Per Business Quant, the three most recent readings for KOD's EBIT are -$59.8 million (Q1 2026), -$57.5 million (Q4 2025), and -$62.4 million (Q3 2025).